A Single Dose Study of SHR0410 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 15, 2018

Primary Completion Date

June 29, 2018

Study Completion Date

July 14, 2018

Conditions
Acute Pain
Interventions
DRUG

0.5μg/kg SHR0410

a single dose of 0.5μg/kg SHR0410

DRUG

1μg/kg SHR0410

a single dose of 2μg/kg SHR0410

DRUG

2μg/kg SHR0410

a single dose of 2μg/kg SHR0410

DRUG

5μg/kg SHR0410

a single dose of 5μg/kg SHR0410

DRUG

10μg/kg SHR0410

a single dose of 10μg/kg SHR0410

DRUG

20μg/kg SHR0410

a single dose of 20μg/kg SHR0410

Trial Locations (1)

Unknown

Linear Clinical Research Limited, Nedlands

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Linear Clinical Research

INDUSTRY

lead

Atridia Pty Ltd.

INDUSTRY

NCT03493191 - A Single Dose Study of SHR0410 in Healthy Male Participants | Biotech Hunter | Biotech Hunter